文献速递生殖医学

基于RT-qPCR基因表达分析的新型全面可靠子宫内膜容受性图谱(ER Map/ER Grade)的建立

Development of a new comprehensive and reliable endometrial receptivity map (ER Map/ER Grade) based on RT-qPCR gene expression analysis.
PubMed 文献 · Hum Reprod · 2018-01-01

研究在2014年7月至2016年3月间对312份子宫内膜样本(96例自然周期可生育女性LH+2和LH+7及120例激素替代周期助孕患者窗口期)进行184个基因RT-qPCR表达分析,筛选出40个差异基因可将样本分为增殖期、容受前期、容受期和容受后期,提出ER Map/ER Grade检测可预测子宫内膜容受状态。

要点

  • ER Map/ER Grade检测基于184个基因中40个差异表达基因的RT-qPCR分析分类子宫内膜容受状态。
  • 可生育女性LH+2与LH+7样本间184个基因中85个表达有显著差异(配对t检验,P<0.05)。
  • 作者指出需进一步开展非选择研究和随机对照试验评估该工具对助孕结局的改善效果。

核心结论

  • 新型ER Map/ER Grade检测可通过涉及子宫内膜增殖和母体免疫应答的基因panel的RT-qPCR预测子宫内膜容受状态。

研究设计与样本

  • ER Map/ER Grade验证于2014年7月至2016年3月进行,纳入312份子宫内膜样本,包括96例可生育女性和120例助孕治疗患者。
  • 可生育女性自然周期于LH+2和LH+7取子宫内膜活检,助孕患者在激素替代周期窗口期取样。
  • 对184个参与子宫内膜容受性和免疫应答的基因进行表达分析,并用独立的子宫内膜容受性检测额外测试样本。

主要发现

  • 可生育女性LH+2与LH+7样本比较,184个基因中85个表达水平有显著差异(配对t检验,P<0.05)。
  • 基因本体分析显示细胞分裂与增殖、细胞信号与反应、细胞外组织与通讯、免疫活性、血管增殖、血压调节和胚胎植入是过代表最多的生物学条目。
  • 主成分分析和判别功能分析显示40个差异表达基因可在可生育组和不孕组中准确将样本分类为增殖期、容受前期、容受期和容受后期。

关键数值与推荐

  • ER Map/ER Grade检测通过RT-qPCR分析40个差异表达基因将子宫内膜容受状态分为增殖期、容受前期、容受期和容受后期四组。

临床怎么用

  • 作者认为识别胚胎移植的最佳时间对最大化助孕效果至关重要,该研究是生殖医学个体化医疗领域的新一步,可能有助于胚胎移植的子宫内膜准备管理。

局限性

  • 为评估该新工具改善助孕结局的效果,还需进一步开展非选择研究和随机对照试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is it possible to determine the receptivity status of an endometrium by combined quantitative reverse transcription PCR (RT-qPCR) expression analysis of genes involved in endometrial proliferation and immunity? SUMMARY ANSWER: The new ER Map®/ER Grade® test can predict endometrial receptivity status by RT-qPCR using a new panel of genes involved in endometrial proliferation and the maternal immune response associated to embryonic implantation. WHAT IS KNOWN ALREADY: The human endometrium reaches a receptive status adequate for embryonic implantation around Days 19-21 of the menstrual cycle. During this period, known as the window of implantation (WOI), the endometrium shows a specific gene expression profile suitable for endometrial function evaluation. The number of molecular diagnostic tools currently available to characterize this process is very limited. In this study, a new system for human endometrial receptivity evaluation was optimized and presented for the first time. STUDY DESIGN, SIZE, DURATION: ER Map®/ER Grade® validation was achieved on 312 endometrial samples including fertile women and patients undergoing fertility treatment between July 2014 and March 2016. Expression analyses of 184 genes involved in endometrial receptivity and immune response were performed. Samples were additionally tested with an independent endometrial receptivity test. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 96 fertile women and 120 assisted reproduction treatment (ART) patients participated in the study. Endometrial biopsy samples were obtained at LH + 2 and LH + 7 days in fertile subjects in a natural cycle and at the window of implantation (WOI) in patients in a hormone-replacement therapy (HRT) cycle. Total RNA was purified, quality-checked and reverse-transcribed. Gene expression was quantified by high-throughput RT-qPCR and statistically analyzed. Informative genes were selected and used to classify samples into four different groups of endometrial receptivity status. MAIN RESULTS AND THE ROLE OF CHANCE: Significantly different gene expression levels were found in 85 out of 184 selected genes when comparing LH + 2 and LH + 7 samples (paired t-test, P < 0.05). Gene ontology analyses revealed that cell division and proliferation, cell signaling and response, extracellular organization and communication, immunological activity, vascular proliferation, blood pressure regulation and embryo implantation are the most over-represented biological terms in this group of genes. Principal component analysis and discriminant functional analysis showed that 40 of the differentially expressed genes allowed accurate classification of samples according to endometrial status (proliferative, pre-receptive, receptive and post-receptive) in both fertile and infertile groups. LARGE SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: To evaluate the efficacy of this new tool to improve ART outcomes, further investigations such as non-selection studies and randomized controlled trials will also be required. WIDER IMPLICATIONS OF THE FINDINGS: A new comprehensive system for human endometrial receptivity evaluation based on gene expression analysis has been developed. The identification of the optimal time for embryo transfer is essential to maximize the effectiveness of ART. This study is a new step in the field of personalized medicine in human reproduction which may help in the management of endometrial preparation for embryo transfer, increasing the chances of pregnancy for many couples. STUDY FUNDING/COMPETING INTEREST(S): The authors have no potential conflict of interest to declare. No external funding was obtained for this study.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Enciso M, Carrascosa JP, Sarasa J, et al. Development of a new comprehensive and reliable endometrial receptivity map (ER Map/ER Grade) based on RT-qPCR gene expression analysis. Hum Reprod. 2018. PMID: 29315421. doi:10.1093/humrep/dex370

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。